212 related articles for article (PubMed ID: 27281612)
21. Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion.
Santio NM; Vahakoski RL; Rainio EM; Sandholm JA; Virtanen SS; Prudhomme M; Anizon F; Moreau P; Koskinen PJ
Mol Cancer; 2010 Oct; 9():279. PubMed ID: 20958956
[TBL] [Abstract][Full Text] [Related]
22. Notch signaling dynamics in the adult healthy prostate and in prostatic tumor development.
Pedrosa AR; Graça JL; Carvalho S; Peleteiro MC; Duarte A; Trindade A
Prostate; 2016 Jan; 76(1):80-96. PubMed ID: 26419726
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of Notch family members in astrocytomas and medulloblastomas.
Xu P; Yu S; Jiang R; Kang C; Wang G; Jiang H; Pu P
Pathol Oncol Res; 2009 Dec; 15(4):703-10. PubMed ID: 19424825
[TBL] [Abstract][Full Text] [Related]
24. Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion.
Ledet RJ; Ruff SE; Wang Y; Nayak S; Schneider JA; Ueberheide B; Logan SK; Garabedian MJ
Commun Biol; 2021 Jan; 4(1):36. PubMed ID: 33398037
[TBL] [Abstract][Full Text] [Related]
25. Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis.
Kumano K; Masuda S; Sata M; Saito T; Lee SY; Sakata-Yanagimoto M; Tomita T; Iwatsubo T; Natsugari H; Kurokawa M; Ogawa S; Chiba S
Pigment Cell Melanoma Res; 2008 Feb; 21(1):70-8. PubMed ID: 18353145
[TBL] [Abstract][Full Text] [Related]
26. PIM kinases: From survival factors to regulators of cell motility.
Santio NM; Koskinen PJ
Int J Biochem Cell Biol; 2017 Dec; 93():74-85. PubMed ID: 29108877
[TBL] [Abstract][Full Text] [Related]
27. Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors.
Malinen M; Jääskeläinen T; Pelkonen M; Heikkinen S; Väisänen S; Kosma VM; Nieminen K; Mannermaa A; Palvimo JJ
Mol Cell Endocrinol; 2013 Jan; 365(2):270-6. PubMed ID: 23142699
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells.
Yang SL; Ren QG; Zhang T; Pan X; Wen L; Hu JL; Yu C; He QJ
Oncol Rep; 2017 Jan; 37(1):348-356. PubMed ID: 27840976
[TBL] [Abstract][Full Text] [Related]
29. Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299 cells.
Zhang Y; Wang Z; Magnuson NS
Mol Cancer Res; 2007 Sep; 5(9):909-22. PubMed ID: 17855660
[TBL] [Abstract][Full Text] [Related]
30. Pim kinase-dependent inhibition of c-Myc degradation.
Zhang Y; Wang Z; Li X; Magnuson NS
Oncogene; 2008 Aug; 27(35):4809-19. PubMed ID: 18438430
[TBL] [Abstract][Full Text] [Related]
31. Notch1 is involved in migration and invasion of human breast cancer cells.
Wang J; Fu L; Gu F; Ma Y
Oncol Rep; 2011 Nov; 26(5):1295-303. PubMed ID: 21785827
[TBL] [Abstract][Full Text] [Related]
32. Notch signaling enhances FcεRI-mediated cytokine production by mast cells through direct and indirect mechanisms.
Nakano N; Nishiyama C; Yagita H; Hara M; Motomura Y; Kubo M; Okumura K; Ogawa H
J Immunol; 2015 May; 194(9):4535-44. PubMed ID: 25821223
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation-dependent regulation of Notch1 signaling: the fulcrum of Notch1 signaling.
Lee HJ; Kim MY; Park HS
BMB Rep; 2015 Aug; 48(8):431-7. PubMed ID: 26058398
[TBL] [Abstract][Full Text] [Related]
34. The Notch-1 receptor in prostate tumorigenesis.
O'Brien R; Marignol L
Cancer Treat Rev; 2017 May; 56():36-46. PubMed ID: 28457880
[TBL] [Abstract][Full Text] [Related]
35. Pan-PIM kinase inhibition provides a novel therapy for treating hematologic cancers.
Garcia PD; Langowski JL; Wang Y; Chen M; Castillo J; Fanton C; Ison M; Zavorotinskaya T; Dai Y; Lu J; Niu XH; Basham S; Chan J; Yu J; Doyle M; Feucht P; Warne R; Narberes J; Tsang T; Fritsch C; Kauffmann A; Pfister E; Drueckes P; Trappe J; Wilson C; Han W; Lan J; Nishiguchi G; Lindvall M; Bellamacina C; Aycinena JA; Zang R; Holash J; Burger MT
Clin Cancer Res; 2014 Apr; 20(7):1834-45. PubMed ID: 24474669
[TBL] [Abstract][Full Text] [Related]
36. Notch3 activation promotes invasive glioma formation in a tissue site-specific manner.
Pierfelice TJ; Schreck KC; Dang L; Asnaghi L; Gaiano N; Eberhart CG
Cancer Res; 2011 Feb; 71(3):1115-25. PubMed ID: 21245095
[TBL] [Abstract][Full Text] [Related]
37. Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer.
Toth RK; Warfel NA
Mol Cancer Ther; 2021 Jan; 20(1):3-10. PubMed ID: 33303645
[TBL] [Abstract][Full Text] [Related]
38. Constitutive NOTCH3 Signaling Promotes the Growth of Basal Breast Cancers.
Choy L; Hagenbeek TJ; Solon M; French D; Finkle D; Shelton A; Venook R; Brauer MJ; Siebel CW
Cancer Res; 2017 Mar; 77(6):1439-1452. PubMed ID: 28108512
[TBL] [Abstract][Full Text] [Related]
39. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
[TBL] [Abstract][Full Text] [Related]
40. Notch signaling in lung diseases: focus on Notch1 and Notch3.
Zong D; Ouyang R; Li J; Chen Y; Chen P
Ther Adv Respir Dis; 2016 Oct; 10(5):468-84. PubMed ID: 27378579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
